Literature DB >> 19351597

CtBP1/BARS Gly172-->Glu mutant structure: impairing NAD(H)-binding and dimerization.

Marco Nardini1, Carmen Valente, Stefano Ricagno, Alberto Luini, Daniela Corda, Martino Bolognesi.   

Abstract

C-terminal binding proteins (CtBPs) are multi-functional proteins involved in nuclear transcriptional co-repression, Golgi membrane fission, and synaptic ribbon formation. Binding of NAD(H) to CtBPs promotes dimerization. CtBP dimers act as a scaffold for multimeric protein complex formation, thus bridging transcriptional repressors and their targets in the nucleus. Based on size-exclusion chromatography experiments and on the crystal structure of the NAD(H)-free G172E CtBP mutant, we show here that absence of NAD(H) induces flexibility/backbone conformational changes at the dimerization interface and at the CtBP interdomain region. The results presented shed first light on the correlation between NAD(H)-binding and functional CtBP dimerization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351597     DOI: 10.1016/j.bbrc.2009.02.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development.

Authors:  Yang W Zhang; David N Arnosti
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

2.  Assembly of human C-terminal binding protein (CtBP) into tetramers.

Authors:  Andrew G Bellesis; Anne M Jecrois; Janelle A Hayes; Celia A Schiffer; William E Royer
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

3.  Nicotinamide adenine dinucleotide-dependent binding of the neuronal Ca2+ sensor protein GCAP2 to photoreceptor synaptic ribbons.

Authors:  Jagadeesh Kumar Venkatesan; Sivaraman Natarajan; Karin Schwarz; Sabine I Mayer; Kannan Alpadi; Venkat Giri Magupalli; Ching-Hwa Sung; Frank Schmitz
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

4.  The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets.

Authors:  Chandan Bhambhani; Jinhee L Chang; David L Akey; Ken M Cadigan
Journal:  EMBO J       Date:  2011-04-05       Impact factor: 11.598

5.  Nicotinamide adenine dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a switching tryptophan.

Authors:  Dana L Madison; Jacqueline A Wirz; Don Siess; James R Lundblad
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

Review 6.  Components of the CtBP1/BARS-dependent fission machinery.

Authors:  Carmen Valente; Alberto Luini; Daniela Corda
Journal:  Histochem Cell Biol       Date:  2013-09-01       Impact factor: 4.304

7.  Cryo-EM structure of CtBP2 confirms tetrameric architecture.

Authors:  Anne M Jecrois; M Michael Dcona; Xiaoyan Deng; Dipankar Bandyopadhyay; Steven R Grossman; Celia A Schiffer; William E Royer
Journal:  Structure       Date:  2020-12-01       Impact factor: 5.871

8.  Golgi membrane fission requires the CtBP1-S/BARS-induced activation of lysophosphatidic acid acyltransferase δ.

Authors:  Alessandro Pagliuso; Carmen Valente; Lucia Laura Giordano; Angela Filograna; Guiling Li; Diego Circolo; Gabriele Turacchio; Vincenzo Manuel Marzullo; Luigi Mandrich; Mikhail A Zhukovsky; Fabio Formiggini; Roman S Polishchuk; Daniela Corda; Alberto Luini
Journal:  Nat Commun       Date:  2016-07-12       Impact factor: 14.919

9.  ANGUSTIFOLIA, a Plant Homolog of CtBP/BARS Localizes to Stress Granules and Regulates Their Formation.

Authors:  Hemal Bhasin; Martin Hülskamp
Journal:  Front Plant Sci       Date:  2017-06-13       Impact factor: 5.753

Review 10.  The Structure and Function of Acylglycerophosphate Acyltransferase 4/ Lysophosphatidic Acid Acyltransferase Delta (AGPAT4/LPAATδ).

Authors:  Mikhail A Zhukovsky; Angela Filograna; Alberto Luini; Daniela Corda; Carmen Valente
Journal:  Front Cell Dev Biol       Date:  2019-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.